BridgeBio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil exercised options for 71,216 BridgeBio Pharma, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Kumar Neil (Director, Chief Executive Officer) exercised options for 71,216 BridgeBio Pharma, Inc. shares, leaving 278,307 shares. Filed Nov 18, 2026 (Form 4).

Options exercised
71,216 shares
Holding after
278,307 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockOption exercise33,544276,871Direct
Nov 16, 2026Common StockOption exercise19,599296,470Direct
Nov 16, 2026Common StockOption exercise11,554308,024Direct
Nov 16, 2026Common StockOption exercise6,519314,543Direct
Nov 16, 2026Common StockShares withheld for tax36,236US$77.36278,307Direct

Source

Download original · View original at SEC

Related